Serafin Andrew's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Dec 5, 2022
- Accession no.
- 0001415889-22-012041
- Filed
- Dec 5, 2022
- Trade date
- Dec 2, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.29M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Serafin AndrewCIK 0001821460 | Officer (CHIEF STRATEGY OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Common Stock | MOption exerciseAcquired | +38,000 | $8.22 | +$312,360 | 38,000 | Direct | |
| Dec 2, 2022 | Common Stock | SSaleDisposed | −37,080 | $60.12 | −$2,229,249.6 | 920 | Direct | |
| Dec 2, 2022 | Common Stock | SSaleDisposed | −920 | $60.71 | −$55,853.2 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Common Stock | MOption exerciseDisposed | −38,000 | $0.00 | $0 | 83,729 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.